[
    {
        "contents": "data\\NVC\\20161218-220101.news",
        "description": null,
        "guid": "yahoo_finance/2739859664",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/boston-scientific-acquires-neovasc-boost-132401627.html",
        "pubDate": "Wed, 14 Dec 2016 13:24:01 GMT",
        "source": "data\\NVC\\20161218.rss",
        "title": "Boston Scientific Acquires Neovasc to Boost Heart Business"
    },
    {
        "contents": "data\\NVC\\20161218-220103.news",
        "description": "[PR Newswire] - MARLBOROUGH, Mass., Dec. 13, 2016 /PRNewswire/ -- Boston Scientific Corporation (BSX) today announced the close of its acquisition of certain manufacturing assets and capabilities of the Neovasc, Inc., (NVCN) (NVC.TO) advanced biological tissue business. The two organizations announced a definitive agreement on December 2, 2016 for Boston Scientific to acquire the advanced biologic tissue capabilities and make a 15% equity investment in Neovasc, for a total of $75 million in cash. The common shares were acquired for investment purposes.",
        "guid": "yahoo_finance/3473028618",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/boston-scientific-closes-acquisition-advanced-120000813.html",
        "pubDate": "Tue, 13 Dec 2016 12:00:00 GMT",
        "source": "data\\NVC\\20161218.rss",
        "title": "Boston Scientific Closes Acquisition of Advanced Biological Tissue Capabilities and Acquires Common Shares of Neovasc, Inc."
    },
    {
        "contents": "data\\NVC\\20161218-220105.news",
        "description": "[CNW Group] - Neovasc and Boston Scientific Close US$75 Million Agreement",
        "guid": "yahoo_finance/2547157648",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/neovasc-boston-scientific-close-us-120000034.html",
        "pubDate": "Tue, 13 Dec 2016 12:00:00 GMT",
        "source": "data\\NVC\\20161218.rss",
        "title": "Neovasc and Boston Scientific Close US$75 Million Agreement"
    },
    {
        "contents": "data\\NVC\\20161218-220106.news",
        "description": "[PR Newswire] - VANCOUVER, Dec. 13, 2016 /PRNewswire/ - Neovasc Inc. (\"Neovasc\" or the \"Company\") (NVCN) (NVC.TO) today announced the close of its transaction with Boston Scientific Corporation (BSX). The two organizations announced a definitive agreement on December 2, 2016 for Boston Scientific to acquire Neovasc's advanced biologic tissue capabilities and certain manufacturing assets and make a 15% equity investment in Neovasc, for a total of US$75 million in cash. Under the terms of the asset purchase agreement Neovasc has been granted a license to the purchased assets and access to the sold facilities to allow it to continue its tissue and valve assembly activities for its remaining customers, and continue its own tissue-related programs, including advancing its mitral bioprosthesis valve Tiara\u2122 through its clinical and regulatory pathways.",
        "guid": "yahoo_finance/2210013257",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/neovasc-boston-scientific-close-us-120000107.html",
        "pubDate": "Tue, 13 Dec 2016 12:00:00 GMT",
        "source": "data\\NVC\\20161218.rss",
        "title": "Neovasc and Boston Scientific Close US$75 Million Agreement"
    },
    {
        "contents": "data\\NVC\\20161218-220108.news",
        "description": null,
        "guid": "yahoo_finance/4168946095",
        "link": "http://us.rd.yahoo.com/finance/external/xcapitalcube/rss/SIG=13og95ro6/*http://www.capitalcube.com/blog/index.php/neovasc-inc-nvc-ca-earnings-analysis-q3-2016-by-the-numbers-december-9-2016/",
        "pubDate": "Fri, 09 Dec 2016 13:17:47 GMT",
        "source": "data\\NVC\\20161218.rss",
        "title": "Neovasc, Inc. :NVC-CA: Earnings Analysis: Q3, 2016 By the Numbers : December 9, 2016"
    },
    {
        "contents": "data\\NVC\\20161218-220111.news",
        "description": "[CNW Group] - Neovasc Provides Update on its Tiara\u2122 Mitral Valve Clinical Program",
        "guid": "yahoo_finance/916082687",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/neovasc-provides-tiara-mitral-valve-120000677.html",
        "pubDate": "Tue, 06 Dec 2016 12:00:00 GMT",
        "source": "data\\NVC\\20161218.rss",
        "title": "Neovasc Provides Update on its Tiara\u2122 Mitral Valve Clinical Program"
    },
    {
        "contents": "data\\NVC\\20161218-220112.news",
        "description": "[PR Newswire] - VANCOUVER, Dec. 6, 2016 /PRNewswire/ - Neovasc Inc. (\"Neovasc\" or the \"Company\") (NVCN) (NVC.TO) today provided an update on the clinical experience with its Tiara\u2122 transcatheter mitral valve. Tiara\u2122 is a novel transcatheter device designed to treat mitral regurgitation (MR), a condition that is often severe and can lead to heart failure and death. There have been no reported adverse events related to the valve performance. There have been no frame fractures, or any device performance issues observed with the Tiara\u2122 in any patient follow-up.",
        "guid": "yahoo_finance/548292199",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/neovasc-provides-tiara-mitral-valve-120000310.html",
        "pubDate": "Tue, 06 Dec 2016 12:00:00 GMT",
        "source": "data\\NVC\\20161218.rss",
        "title": "Neovasc Provides Update on its Tiara\u2122 Mitral Valve Clinical Program"
    },
    {
        "contents": "data\\NVC\\20161218-220114.news",
        "description": null,
        "guid": "yahoo_finance/3885651766",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/boston-scientific-bsx-inks-75-131001751.html",
        "pubDate": "Mon, 05 Dec 2016 13:10:01 GMT",
        "source": "data\\NVC\\20161218.rss",
        "title": "Boston Scientific (BSX) Inks $75 Million Deal with Neovasc"
    },
    {
        "contents": "data\\NVC\\20161218-220117.news",
        "description": "[CNW Group] - Neovasc and Boston Scientific Reach US$75 Million Agreement",
        "guid": "yahoo_finance/1284239949",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/neovasc-boston-scientific-reach-us-120000841.html",
        "pubDate": "Fri, 02 Dec 2016 12:00:00 GMT",
        "source": "data\\NVC\\20161218.rss",
        "title": "Neovasc and Boston Scientific Reach US$75 Million Agreement"
    },
    {
        "contents": "data\\NVC\\20161218-220118.news",
        "description": "[PR Newswire] - VANCOUVER, Dec. 2, 2016 /PRNewswire/ - Neovasc Inc. (\"Neovasc\" or the \"Company\") (NVCN) (NVC.TO) today announced that Boston Scientific Corporation (BSX), a global medical technology leader, has agreed to acquire Neovasc's tissue processing technology and facility for approximately US$67,909,800. Concurrently, Boston Scientific has committed to invest an additional US$7,090,200 in Neovasc for a 15% equity interest in the Company.",
        "guid": "yahoo_finance/1233513445",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/neovasc-boston-scientific-reach-us-120000849.html",
        "pubDate": "Fri, 02 Dec 2016 12:00:00 GMT",
        "source": "data\\NVC\\20161218.rss",
        "title": "Neovasc and Boston Scientific Reach US$75 Million Agreement"
    },
    {
        "contents": "data\\NVC\\20161218-220120.news",
        "description": "[PR Newswire] - MARLBOROUGH, Mass., Dec. 2, 2016 /PRNewswire/ -- Boston Scientific Corporation (BSX) today announced a definitive agreement to acquire certain manufacturing assets and capabilities of the Neovasc, Inc., (NVCN) (NVC.TO) advanced biological tissue business, as well as a 15% equity stake in Neovasc, for a total of $75 million in cash. \"We continually seek ways to optimize our manufacturing processes and enhance our product portfolio,\" said Ed Mackey, executive vice president, operations, Boston Scientific. The acquisition is expected to close by year-end 2016, subject to customary closing conditions, and to be immaterial to Boston Scientific earnings per share (EPS) in 2016 and 2017 on an adjusted and GAAP basis.",
        "guid": "yahoo_finance/3347114646",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/boston-scientific-announces-agreement-acquire-120000893.html",
        "pubDate": "Fri, 02 Dec 2016 12:00:00 GMT",
        "source": "data\\NVC\\20161218.rss",
        "title": "Boston Scientific Announces Agreement to Acquire Neovasc Advanced Biological Tissue Capabilities"
    },
    {
        "contents": "data\\NVC\\20161218-220122.news",
        "description": "[CNW Group] - Neovasc Receives Regulatory Approval to Initiate TIARA II CE Mark Study",
        "guid": "yahoo_finance/3247244788",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/neovasc-receives-regulatory-approval-initiate-120000018.html",
        "pubDate": "Mon, 28 Nov 2016 12:00:00 GMT",
        "source": "data\\NVC\\20161218.rss",
        "title": "Neovasc Receives Regulatory Approval to Initiate TIARA II CE Mark Study"
    },
    {
        "contents": "data\\NVC\\20161218-220123.news",
        "description": "[PR Newswire] - VANCOUVER, Nov. 28, 2016 /PRNewswire/ - Neovasc Inc. (\"Neovasc\" or the \"Company\") (NVCN) (NVC.TO) today announced it has received both regulatory and ethics committee approval to initiate the Tiara\u2122 Transcatheter Mitral Valve Replacement Study (TIARA II) in Italy. TIARA II is a 115 patient, non-randomized, prospective clinical study evaluating the safety and performance of the Tiara\u2122 Transcatheter Mitral Valve with the Tiara\u2122 Transapical Delivery System (Tiara\u2122). With these critical approvals now in place, it is expected that the first Italian TIARA II clinical study site will be initiated before year end, with first enrollment anticipated early in the new year. Approvals in additional geographies are expected in the first quarter of 2017.",
        "guid": "yahoo_finance/334527316",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/neovasc-receives-regulatory-approval-initiate-120000300.html",
        "pubDate": "Mon, 28 Nov 2016 12:00:00 GMT",
        "source": "data\\NVC\\20161218.rss",
        "title": "Neovasc Receives Regulatory Approval to Initiate TIARA II CE Mark Study"
    },
    {
        "contents": "data\\NVC\\20161218-220125.news",
        "description": "[PR Newswire] - The Court ruled in favor of the Company and its officers on all claims and ordered the entire case closed. The Company is not aware as to whether, and presently cannot foresee whether, the plaintiff will appeal the dismissal of his claims or will file any post-dismissal motions. Neovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products in development include the Tiara\u2122, for the transcatheter treatment of mitral valve disease and the Neovasc Reducer\u2122 for the treatment of refractory angina.",
        "guid": "yahoo_finance/1057794989",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/neovasc-announces-dismissal-class-action-131400128.html",
        "pubDate": "Wed, 23 Nov 2016 13:14:00 GMT",
        "source": "data\\NVC\\20161218.rss",
        "title": "Neovasc Announces Dismissal of Class Action Lawsuit"
    },
    {
        "contents": "data\\NVC\\20161218-220127.news",
        "description": "[CNW Group] - Neovasc Announces Dismissal of Class Action Lawsuit",
        "guid": "yahoo_finance/736078663",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/neovasc-announces-dismissal-class-action-131400799.html",
        "pubDate": "Wed, 23 Nov 2016 13:14:00 GMT",
        "source": "data\\NVC\\20161218.rss",
        "title": "Neovasc Announces Dismissal of Class Action Lawsuit"
    },
    {
        "contents": "data\\NVC\\20161218-220129.news",
        "description": null,
        "guid": "yahoo_finance/4245923463",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://news.investornetwork.com/2016/11/21/research-reports-initiated-on-healthcare-stocks-titan-medical-crh-medical-neovasc-and-led-medical-diagnostics/?1=1&1479735998",
        "pubDate": "Mon, 21 Nov 2016 13:46:38 GMT",
        "source": "data\\NVC\\20161218.rss",
        "title": "Research Reports Initiated on Healthcare Stocks Titan Medical, CRH Medical, Neovasc, and LED Medical Diagnostics"
    },
    {
        "contents": "data\\NVC\\20161218-220129.news",
        "description": null,
        "guid": "yahoo_finance/2538654880",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/neovasc-reports-3q-loss-211746891.html",
        "pubDate": "Mon, 14 Nov 2016 21:17:46 GMT",
        "source": "data\\NVC\\20161218.rss",
        "title": "Neovasc reports 3Q loss"
    },
    {
        "contents": "data\\NVC\\20161218-220131.news",
        "description": null,
        "guid": "yahoo_finance/3984830965",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/neovasc-reports-3q-loss-211746933.html",
        "pubDate": "Mon, 14 Nov 2016 21:17:46 GMT",
        "source": "data\\NVC\\20161218.rss",
        "title": "Neovasc reports 3Q loss"
    },
    {
        "contents": "data\\NVC\\20161218-220132.news",
        "description": "[CNW Group] - Neovasc Reports Third Quarter Results for 2016",
        "guid": "yahoo_finance/2536474934",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/neovasc-reports-third-quarter-results-210000917.html",
        "pubDate": "Mon, 14 Nov 2016 21:00:00 GMT",
        "source": "data\\NVC\\20161218.rss",
        "title": "Neovasc Reports Third Quarter Results for 2016"
    },
    {
        "contents": "data\\NVC\\20161218-220134.news",
        "description": "[PR Newswire] - NASDAQ: NVCN TSX: NVC VANCOUVER, Nov. 14, 2016 /PRNewswire/ - Neovasc Inc. (\" Neovasc \" or the \" Company \") (NASDAQ: NVCN) (TSX: NVC) today announced financial results for the quarter ...",
        "guid": "yahoo_finance/4294484370",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/neovasc-reports-third-quarter-results-210000445.html",
        "pubDate": "Mon, 14 Nov 2016 21:00:00 GMT",
        "source": "data\\NVC\\20161218.rss",
        "title": "Neovasc Reports Third Quarter Results for 2016"
    },
    {
        "contents": "data\\NVC\\20161220-121146.news",
        "description": null,
        "guid": "yahoo_finance/1011695058",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/iiroc-trading-halt-nvc-165900327.html",
        "pubDate": "Tue, 20 Dec 2016 16:59:00 GMT",
        "source": "data\\NVC\\20161220.rss",
        "title": "IIROC Trading Halt - NVC"
    },
    {
        "contents": "data\\NVC\\20161220-121148.news",
        "description": null,
        "guid": "yahoo_finance/1755169646",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/iiroc-trading-halt-nvc-165900712.html",
        "pubDate": "Tue, 20 Dec 2016 16:59:00 GMT",
        "source": "data\\NVC\\20161220.rss",
        "title": "IIROC Trading Halt - NVC"
    },
    {
        "contents": "data\\NVC\\20161220-121150.news",
        "description": "[PR Newswire] - VANCOUVER, Dec. 19, 2016 /PRNewswire/ - Neovasc Inc. (\"Neovasc\" or the \"Company\") (NVCN) (NVC.TO) announced today that the Company has regained compliance with the listing requirements of The NASDAQ Stock Market LLC (\"Nasdaq\"). As previously reported, on July 5, 2016, Neovasc received a letter from Nasdaq notifying the Company that it was not in compliance with the minimum bid price requirement set forth in the Nasdaq Rules for continued listing on The Nasdaq Capital Market.",
        "guid": "yahoo_finance/3958415822",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/neovasc-regains-compliance-nasdaq-listing-185600507.html",
        "pubDate": "Mon, 19 Dec 2016 18:56:00 GMT",
        "source": "data\\NVC\\20161220.rss",
        "title": "Neovasc Regains Compliance with NASDAQ Listing Requirements"
    },
    {
        "contents": "data\\NVC\\20161220-121152.news",
        "description": "[CNW Group] - Neovasc Regains Compliance with NASDAQ Listing Requirements",
        "guid": "yahoo_finance/3464058728",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/neovasc-regains-compliance-nasdaq-listing-185600277.html",
        "pubDate": "Mon, 19 Dec 2016 18:56:00 GMT",
        "source": "data\\NVC\\20161220.rss",
        "title": "Neovasc Regains Compliance with NASDAQ Listing Requirements"
    },
    {
        "contents": "data\\NVC\\20161220-132727.news",
        "description": null,
        "guid": "yahoo_finance/3524250687",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/iiroc-trade-resumption-nvc-171000225.html",
        "pubDate": "Tue, 20 Dec 2016 17:10:00 GMT",
        "source": "data\\NVC\\20161220.rss",
        "title": "IIROC Trade Resumption - NVC"
    },
    {
        "contents": "data\\NVC\\20161220-132728.news",
        "description": null,
        "guid": "yahoo_finance/1649580690",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/iiroc-trade-resumption-nvc-171000114.html",
        "pubDate": "Tue, 20 Dec 2016 17:10:00 GMT",
        "source": "data\\NVC\\20161220.rss",
        "title": "IIROC Trade Resumption - NVC"
    },
    {
        "contents": "data\\NVC\\20161226-093813.news",
        "description": null,
        "guid": "yahoo_finance/1546810348",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/iiroc-trade-resumption-nvc-174700479.html",
        "pubDate": "Fri, 23 Dec 2016 17:47:00 GMT",
        "source": "data\\NVC\\20161226.rss",
        "title": "IIROC Trade Resumption - NVC"
    },
    {
        "contents": "data\\NVC\\20161226-093815.news",
        "description": null,
        "guid": "yahoo_finance/4289301023",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/iiroc-trade-resumption-nvc-174700197.html",
        "pubDate": "Fri, 23 Dec 2016 17:47:00 GMT",
        "source": "data\\NVC\\20161226.rss",
        "title": "IIROC Trade Resumption - NVC"
    },
    {
        "contents": "data\\NVC\\20161226-093816.news",
        "description": "[CNW Group] - Neovasc Announces Update in Litigation with CardiAQ",
        "guid": "yahoo_finance/3482770628",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/neovasc-announces-litigation-cardiaq-172800725.html",
        "pubDate": "Fri, 23 Dec 2016 17:28:00 GMT",
        "source": "data\\NVC\\20161226.rss",
        "title": "Neovasc Announces Update in Litigation with CardiAQ"
    },
    {
        "contents": "data\\NVC\\20161226-093824.news",
        "description": "[PR Newswire] - VANCOUVER, Dec. 23, 2016 /PRNewswire/ - Neovasc Inc. (\"Neovasc\" or the \"Company\") (NVCN) (NVC.TO) reported today that the United States District Court for the District of Massachusetts has granted a stay of judgment pending the completion of its appeal.",
        "guid": "yahoo_finance/73795423",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/neovasc-announces-litigation-cardiaq-172800504.html",
        "pubDate": "Fri, 23 Dec 2016 17:28:00 GMT",
        "source": "data\\NVC\\20161226.rss",
        "title": "Neovasc Announces Update in Litigation with CardiAQ"
    },
    {
        "contents": "data\\NVC\\20161226-093826.news",
        "description": null,
        "guid": "yahoo_finance/1289448709",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/iiroc-trading-halt-nvc-172000178.html",
        "pubDate": "Fri, 23 Dec 2016 17:20:00 GMT",
        "source": "data\\NVC\\20161226.rss",
        "title": "IIROC Trading Halt - NVC"
    },
    {
        "contents": "data\\NVC\\20161226-093827.news",
        "description": null,
        "guid": "yahoo_finance/3602132033",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/iiroc-trading-halt-nvc-172000725.html",
        "pubDate": "Fri, 23 Dec 2016 17:20:00 GMT",
        "source": "data\\NVC\\20161226.rss",
        "title": "IIROC Trading Halt - NVC"
    },
    {
        "contents": "data\\NVC\\20161230-090307.news",
        "description": null,
        "guid": "yahoo_finance/1322850748",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/neovasc-reports-2q-loss-203538108.html",
        "pubDate": "Tue, 09 Aug 2016 20:35:38 GMT",
        "source": "data\\NVC\\20161230.rss",
        "title": "Neovasc reports 2Q loss"
    },
    {
        "contents": "data\\NVC\\20161230-090309.news",
        "description": null,
        "guid": "yahoo_finance/632742996",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/neovasc-reports-1q-loss-105337642.html",
        "pubDate": "Fri, 29 Apr 2016 10:53:37 GMT",
        "source": "data\\NVC\\20161230.rss",
        "title": "Neovasc reports 1Q loss"
    },
    {
        "contents": "data\\NVC\\20161230-090311.news",
        "description": null,
        "guid": "yahoo_finance/2705723698",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/neovasc-reports-4q-loss-211542089.html",
        "pubDate": "Tue, 29 Mar 2016 21:15:42 GMT",
        "source": "data\\NVC\\20161230.rss",
        "title": "Neovasc reports 4Q loss"
    },
    {
        "contents": "data\\NVC\\20161230-090313.news",
        "description": null,
        "guid": "yahoo_finance/2999260513",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/neovasc-reports-3q-loss-112529435.html",
        "pubDate": "Mon, 09 Nov 2015 11:25:29 GMT",
        "source": "data\\NVC\\20161230.rss",
        "title": "Neovasc reports 3Q loss"
    },
    {
        "contents": "data\\NVC\\20161230-090314.news",
        "description": null,
        "guid": "yahoo_finance/3032009664",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/neovasc-reports-2q-loss-114256560.html",
        "pubDate": "Thu, 06 Aug 2015 11:42:56 GMT",
        "source": "data\\NVC\\20161230.rss",
        "title": "Neovasc reports 2Q loss"
    },
    {
        "contents": "data\\NVC\\20161230-090316.news",
        "description": null,
        "guid": "yahoo_finance/915401624",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/neovasc-reports-1q-loss-112449435.html",
        "pubDate": "Tue, 12 May 2015 11:24:49 GMT",
        "source": "data\\NVC\\20161230.rss",
        "title": "Neovasc reports 1Q loss"
    },
    {
        "contents": "data\\NVC\\20161230-090318.news",
        "description": null,
        "guid": "yahoo_finance/1632079849",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/neovasc-reports-4q-loss-111847689.html",
        "pubDate": "Mon, 30 Mar 2015 11:18:47 GMT",
        "source": "data\\NVC\\20161230.rss",
        "title": "Neovasc reports 4Q loss"
    },
    {
        "contents": "data\\NVC\\20170113-090159.news",
        "description": null,
        "guid": "yahoo_finance/3441741529",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/research-reports-initiated-healthcare-stocks-131500982.html",
        "pubDate": "Fri, 13 Jan 2017 13:15:00 GMT",
        "source": "data\\NVC\\20170113.rss",
        "title": "Research Reports Initiated on Healthcare Stocks Acerus Pharmaceuticals, Neovasc, Nuvo Pharmaceuticals, and Titan Medical"
    },
    {
        "contents": "data\\NVC\\20170118-225907.news",
        "description": "[PR Newswire] - VANCOUVER, Jan. 18, 2017 /PRNewswire/ - Neovasc Inc. (\"Neovasc\" or the \"Company\") (NVCN) (NVC.TO) today announced an update in its ongoing litigation with CardiAQ Valve Technologies, Inc. (\"CardiAQ\"). The Company also sells a line of advanced biological tissue products that are used as key components in third-party medical products including transcatheter heart valves.",
        "guid": "yahoo_finance/1028077873",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/neovasc-announces-litigation-cardiaq-190400537.html",
        "pubDate": "Wed, 18 Jan 2017 19:04:00 GMT",
        "source": "data\\NVC\\20170118.rss",
        "title": "Neovasc Announces Update in Litigation with CardiAQ"
    }
]